AJANTPHARM - Quarterly Results

  2016/Dec 2016/Sep 2016/Jun 2016/Mar 2015/Dec 2015/Sep 2015/Jun 2015/Mar
Sales Income 490.51 464.3 401.06 398.52 416.82 390.33 338.98 363.26
Other Income 51.08 6.68 8.48 41.61 4.2 23.04 13.53 2.84
Other Op Income 18.09 13.44 16.81 6.53 7.07 3.2 5.7 8.48
Expenditure 333.1 308.76 270.0 272.41 270.81 261.95 230.77 235.07
Interest 0.59 0.62 0.88 0.93 1.31 0.93 1.03 1.05
Gross Profit 225.99 175.04 150.59 169.92 152.11 149.66 122.31 135.56
Depreciation 14.73 13.45 12.43 11.55 11.12 10.31 9.7 12.59
Tax 40.28 40.64 38.25 22.66 37.65 44.98 31.55 38.66
PAT 170.98 120.95 99.91 135.71 103.34 94.37 81.06 84.31
Equity null null null null null null null null
OPM (%) 46.19 37.83 38.23 43.24 37.15 38.98 36.83 37.91
GPM (%) 46.07 37.7 38.01 43.0 36.83 38.74 36.52 37.62
NPM (%) 34.86 26.05 25.22 34.35 25.02 24.43 24.21 23.4
Basic EPS 19.42 13.75 11.35 15.42 11.74 10.73 9.21 9.59
Adjusted EPS 19.42 13.75 11.35 15.42 11.74 10.73 9.21 9.59
Diluted EPS 19.33 13.67 11.3 15.34 11.68 10.67 9.16 9.54
Reserves 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Face Value 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
Equity (In Crs) 17.69 17.69 17.69 17.69 17.69 17.69 17.69 17.68
Public Share Holding(%) 0.0 0.0 0.0 0.0 0.0 26.22 26.22 26.17
Pledged Shares(%) 0.0 0.0 0.0 0.0 0.0 3.01 1.14 1.2
Promoters Pledged Shares(%) 0.0 0.0 0.0 0.0 0.0 4.08 1.54 1.62